Astrazeneca AB v Apotex Pty Ltd; Astrazeneca AB v Watson Pharma Pty Ltd; Astrazeneca AB v Ascent Pharma Pty Ltd

The High Court has unanimously dismissed an appeal from a decision of the Full Federal Court relating to novelty and the inventive step in s 7 of the Patents Act 1990 (Cth). Astrazeneca holds the patent relating to a method of treating high blood cholesterol using a compound called rosuvastatin, marketed under the drug name Crestor. The respondent drug companies produce and sell Continue reading